Anavex Life Sciences (AVXL) EBIT Growth (5y) (2021 - 2025)
Anavex Life Sciences (AVXL) EBIT Growth (5y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Anavex Life Sciences | 229.83 Mn | 98.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19.23% |
| Sep 30, 2025 | -26.20% |
| Jun 30, 2025 | -26.78% |
| Mar 31, 2025 | -35.70% |
| Dec 31, 2024 | -25.38% |
| Sep 30, 2024 | -57.23% |
| Jun 30, 2024 | -62.06% |
| Mar 31, 2024 | -28.84% |
| Dec 31, 2023 | -10.98% |
| Sep 30, 2023 | -31.63% |
| Jun 30, 2023 | -49.74% |
| Mar 31, 2023 | -33.06% |
| Dec 31, 2022 | -31.60% |
| Sep 30, 2022 | -158.37% |
| Jun 30, 2022 | -32.07% |
| Mar 31, 2022 | -53.76% |
| Dec 31, 2021 | -33.30% |
| Sep 30, 2021 | 74.55% |
| Jun 30, 2021 | 147.82% |